ahlam1399
09-10-2015, 05:53 PM
Pfizer loses UK patent case over use of Lyrica drug in pain
LONDON (Reuters) - Pfizer suffered a major setback in Britain on Thursday when the High Court in London ruled that claims of patent protection for the use of its $5 billion-a-year drug Lyrica as a pain treatment were invalid.
http://rc.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/rc/1/rc.img (http://rc.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/rc/2/rc.img (http://rc.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/rc/3/rc.img (http://rc.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/rc/3/rc.htm)
http://da.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/a2.img (http://da.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/a2.htm)
http://adchoice.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/ach.img (http://adchoice.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/ach.htm)http://pi.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/a2t.imghttp://pi2.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/49bb4567/sc/3/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=cxUcVCDhKfM:cal_vwlCYwc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=cxUcVCDhKfM:cal_vwlCYwc:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=cxUcVCDhKfM:cal_vwlCYwc:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=cxUcVCDhKfM:cal_vwlCYwc:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=cxUcVCDhKfM:cal_vwlCYwc:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/cxUcVCDhKfM
LONDON (Reuters) - Pfizer suffered a major setback in Britain on Thursday when the High Court in London ruled that claims of patent protection for the use of its $5 billion-a-year drug Lyrica as a pain treatment were invalid.
http://rc.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/rc/1/rc.img (http://rc.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/rc/2/rc.img (http://rc.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/rc/3/rc.img (http://rc.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/rc/3/rc.htm)
http://da.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/a2.img (http://da.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/a2.htm)
http://adchoice.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/ach.img (http://adchoice.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/ach.htm)http://pi.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/a2t.imghttp://pi2.feedsportal.com/r/238385502940/u/49/f/654207/c/35217/s/49bb4567/sc/3/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/49bb4567/sc/3/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=cxUcVCDhKfM:cal_vwlCYwc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=cxUcVCDhKfM:cal_vwlCYwc:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=cxUcVCDhKfM:cal_vwlCYwc:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=cxUcVCDhKfM:cal_vwlCYwc:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=cxUcVCDhKfM:cal_vwlCYwc:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/cxUcVCDhKfM